FDA-2: Frenchay Dysarthria Assessment-Second Edition

The second edition of Frenchay Dysarthria Assessment (FDA-2) includes new powerful knowledge about motor speech disorders and their contribution to neurological diagnosis. This updated edition remains a well-established test for the measurement, differential description, and diagnosis of dysarthria. It can be used in international research, as well as all clinical settings. Norms are provided for ages 12 to 97.FDA-2 is quick and simple to administer, accurate, reliable, and cost-efficient. The client is rated on a number of simple performance tasks related to speech function. It is divided into eight sections:

Pamela Enderby • Rebecca Palmer